Study of Ubrogepant for Migraine During the Prodrome Phase
Part of Brain & nervous system clinical trials.
This study looks at how well the migraine medication ubrogepant works when taken during the early signs of a migraine (prodrome). It may help people who already use ubrogepant for their migraines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have 4 to 10 migraine days each month with moderate to severe headache pain (or you have chronic migraine but this number due to preventive treatment).
- You have been prescribed ubrogepant and have been using it for at least 3 months for migraines.
- You are an adult (age 18 or older) with a diagnosis of migraine or chronic migraine.
- You are not currently in another clinical study.
- You are not taking a strong CYP3A4 inhibitor (a type of medication that can affect how ubrogepant works).
- You do not have other specific headache disorders like new persistent daily headache or trigeminal autonomic cephalgia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how safe ubrogepant is and whether it helps treat an individual migraine attack in children and teens. It focuses on measuring side effects and whether headaches improve 2 hours after taking the study medicine.
This study follows kids and teens who already took part in an earlier migraine medication study to check long-term safety and comfort with oral ubrogepant tablets. It may help families understand whether this migraine tablet is safe to keep using over time.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
This study tests an oral medication called atogepant to prevent migraines in adults in the UK. It aims to see how well it works when prescribed by a general practitioner in primary care.
This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.
This study tests whether rimegepant, a migraine medication, can help prevent migraines in women. It looks at how well it works in real-life settings for women who have frequent migraines.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.